-
Forward Look
Getting PersonalHealth care experts push for care that focuses on the patient.
by Alanna Kennedy-Gorman
-
Forward Look
Avastin’s FateDebate goes on as FDA revokes drug's use for breast cancer.
by Alanna Kennedy-Gorman
-
Staying the CoursePatients are increasingly skipping treatment breaks and opting for ongoing treatment known as maintenance therapy to try to keep some types of cancer at bay.
by Melissa Weber
-
The Birth of a Targeted TherapyA serendiptious discovery more than 50 years ago heralded a new age of cancer treatment.
by Jocelyn Selim
-
The Wait for a MatchMany patients in urgent need of bone marrow or stem cell transplants are facing uncertainty.
by Karen Patterson
-
Global Report
Stark Realities in ZambiaAn American cancer survivor's visit to a Southern African nation reveals how doctors are adapting cancer care to meet an overwhelming need.
by Cynthia Ryan
-
Healthy Habits
Get SteamedBroccoli helps fight cancer—when you prepare it like this.
by Tracy Erb Middleton
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
